Document Type: Review Article

Authors

Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: The environmental factors play a role as risk factors of multiple sclerosis (MS). This study aimed at gathering environmental risk factors of MS in the Middle East and North Africa (MENA).
Methods: We used MEDLINE and EMBASE databases by a systematic review method. Out of a total of 123 studies, 16 studies met the eligibility criteria.
Results: Totally, 47 risk factors were assessed as follows: six studies found sunlight exposure as a protective factor with the odds ratio (OR) ranging from 0.06 to 0.57. Six studies evaluated smoking as a risk factor with the OR ranging from 1.69 in all patients to 6.48 in female patients. Four studies supported measles infection as a risk factor with the OR ranging from 1.60 to 3.77, and in 3 studies, stressful events had a significant association with the OR of 1.80, 1.90, and 32.57.
Conclusion: Among 47 assessed risk factors, sunlight exposure, cigarette smoking, measles infection, Epstein-Barr virus (EBV) infection, and stressful events had a significant association with MS.

Keywords

  1. Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology 2014; 83(11): 1022-4.
  2. Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-analyses. Lancet Neurol 2015; 14(3): 263-73.
  3. Wu S, Liu Q, Zhu JM, Wang MR, Li J, Sun MG. Association between the IL7R T244I polymorphism and multiple sclerosis risk: A meta analysis. Neurol Sci 2016; 37(9): 1467-74.
  4. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18(5): 459-80.
  5. Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA. Multiple sclerosis epidemiology in middle east and north africa: A systematic review and meta-analysis. Neuroepidemiology 2015; 44(4): 232-44.
  6. Briggs FBS, Yu JC, Davis MF, Jiangyang J, Fu S, Parrotta E, et al. Multiple sclerosis risk factors contribute to onset heterogeneity. Mult Scler Relat Disord 2019; 28: 11-6.
  7. Tremlett H, Zhu F, Ascherio A, Munger KL. Sun exposure over the life course and associations with multiple sclerosis. Neurology 2018; 90(14): e1191-e1199.
  8. Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA. Multiple sclerosis epidemiology in East Asia, south East Asia and south Asia: A systematic review. Neuroepidemiology 2016; 46(3): 209-21.
  9. Volpato ESN, Betini M, Puga ME, Agarwal A, Cataneo AJM, Oliveira LD, et al. Strategies to optimize MEDLINE and EMBASE search strategies for anesthesiology systematic reviews. An experimental study. Sao Paulo Med J 2018; 136(2): 103-8.
  10. Hempel S, Graham GD, Fu N, Estrada E, Chen AY, Miake-Lye I, et al. A systematic review of modifiable risk factors in the progression of multiple sclerosis. Mult Scler 2017; 23(4): 525-33.
  11. Eskandarieh S, Nedjat S, Abdollahpour I, Azimi AR, Moghadasi AN, Asgari N, et al. Environmental risk factors in neuromyelitis optica spectrum disorder: A case-control study. Acta Neurol Belg 2018; 118(2): 277-87.
  12. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162-73.
  13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13(3): 227-31.
  14. Schumacher GA, Beebe G, Kibler RF, Kurland Lt, Kurtzke JF, Mcdowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552-68.
  15. Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH. Optimal database combinations for literature searches in systematic reviews: A prospective exploratory study. Syst Rev 2017; 6(1): 245.
  16. Guimond C, Lee JD, Ramagopalan SV, Dyment DA, Hanwell H, Giovannoni G, et al. Multiple sclerosis in the Iranian immigrant population of BC, Canada: Prevalence and risk factors. Mult Scler 2014; 20(9): 1182-8.
  17. Sidhom Y, Kacem I, Bayoudh L, Ben Djebara M, Hizem Y, Ben Abdelfettah S, et al. Season of birth and multiple sclerosis in Tunisia. Mult Scler Relat Disord 2015; 4(6): 491-4.
  18. Akhtar S, Alroughani R, Al-Shammari A, Al-Abkal J, Ayad Y. Month of birth and risk of multiple sclerosis in Kuwait: A population-based registry study. Mult Scler 2015; 21(2): 147-54.
  19. Lauer K, Wahl A, Geilenkeuser M. A possible role of an interaction of the age at common childhood infections and selected dietary factors at young age, for the later risk of multiple sclerosis [Online]. [cited 2016]; Available from: URL: https://www.oatext.com/a-possible-role-of-an-interaction-of-the-age-at-common-childhood-infections-and-selected-dietary-factors-at-young-age-for-the-later-risk-of-multiple-sclerosis.php
  20. Najafi S, Ghane M, Yousefzadeh-Chabok S, Amiri M. The high prevalence of the varicella zoster virus in patients with relapsing-remitting multiple sclerosis: A case-control study in the north of Iran. Jundishapur J Microbiol 2016; 9(3): e34158.
  21. Shivappa N, Hebert JR, Behrooz M, Rashidkhani B. dietary inflammatory index and risk of multiple sclerosis in a case-control study from Iran. Neuroepidemiology 2016; 47(1): 26-31.
  22. Mansouri B, Asadollahi S, Heidari K, Fakhri M, Assarzadegan F, Nazari M, et al. Risk factors for increased multiple sclerosis susceptibility in the Iranian population. J Clin Neurosci 2014; 21(12): 2207-11.
  23. Halawani AT, Zeidan ZA, Kareem AM, Alharthi AA, Almalki HA. Sociodemographic, environmental and lifestyle risk factors for multiple sclerosis development in the Western region of Saudi Arabia. A matched case control study. Saudi Med J 2018; 39(8): 808-14.
  24. Al Wutayd O, Mohamed AG, Saeedi J, Al Otaibi H., Al Jumah M. Environmental exposures and the risk of multiple sclerosis in Saudi Arabia. BMC Neurol 2018; 18(1): 86.
  25. Al-Shammri SN, Hanna MG, Chattopadhyay A, Akanji AO. Sociocultural and demographic risk factors for the development of multiple sclerosis in Kuwait: A Case - Control Study. PLoS One 2015; 10(7): e0132106.
  26. Rejali M, Hosseini SM, Kazemi Tabaee MS, Etemadifar M. Assessing the risk factors for multiple sclerosis in women of reproductive age suffering the disease in Isfahan Province. Int J Prev Med 2016; 7: 58.
  27. Eftekharian MM, Ghannad MS, Taheri M, Roshanaei G, Mazdeh M, Musavi M, et al. Frequency of viral infections and environmental factors in multiple sclerosis. Hum Antibodies 2016; 24(1-2): 17-23.
  28. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr 2007; 137(4): 992-8.
  29. Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, et al. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr 2009; 139(12): 2365-72.
  30. Abbasi M, Nabavi SM, Fereshtehnejad SM, Jou NZ, Ansari I, Shayegannejad V, et al. Multiple sclerosis and environmental risk factors: A case-control study in Iran. Neurol Sci 2017; 38(11): 1941-51.
  31. Abdollahpour I, Nedjat S, Sahraian MA, Mansournia MA, Otahal P, van der Mei I. Waterpipe smoking associated with multiple sclerosis: A population-based incident case-control study. Mult Scler 2017; 23(10): 1328-35.
  32. Alonso A, Cook SD, Maghzi AH, Divani AA. A case-control study of risk factors for multiple sclerosis in Iran. Mult Scler 2011; 17(5): 550-5.
  33. Roudbari SA, Ansar MM, Yousefzad A. Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan. J Neurol Sci 2013; 330(1-2): 52-5.
  34. Abdollahpour I, Lizarraga AA, Nedjat S, Mansournia MA, Weinstock-Guttman B. Medical history and multiple sclerosis: A population-based incident case-control study. Neuroepidemiology 2019; 52(1-2): 55-62.
  35. Abdollahpour I, Nedjat S, Mansournia MA, Sahraian MA, van der Mei I. Lifestyle factors and multiple sclerosis: A population-based incident case-control study. Mult Scler Relat Disord 2018; 22: 128-33.
  36. Mouhieddine TH, Darwish H, Fawaz L, Yamout B, Tamim H, Khoury SJ. Risk factors for multiple sclerosis and associations with anti-EBV antibody titers. Clin Immunol 2015; 158(1): 59-66.
  37. Al-Afasy HH, Al-Obaidan MA, Al-Ansari YA, Al-Yatama SA, Al-Rukaibi MS, Makki NI, et al. Risk factors for multiple sclerosis in Kuwait: A population-based case-control study. Neuroepidemiology 2013; 40(1): 30-5.
  38. Maghzi AH, Etemadifar M, Heshmat-Ghahdarijani K, Nonahal S, Minagar A, Moradi V. Cesarean delivery may increase the risk of multiple sclerosis. Mult Scler 2012; 18(4): 468-71.
  39. Hedstrom AK, Olsson T, Alfredsson L. Smoking is a major preventable risk factor for multiple sclerosis. Mult Scler 2016; 22(8): 1021-6.
  40. Briggs FB, Acuna B, Shen L, Ramsay P, Quach H, Bernstein A, et al. Smoking and risk of multiple sclerosis: Evidence of modification by NAT1 variants. Epidemiology 2014; 25(4): 605-14.
  41. Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: Cellular and molecular mechanisms. J Dent Res 2012; 91(2): 142-9.
  42. Petecchia L, Sabatini F, Varesio L, Camoirano A, Usai C, Pezzolo A, et al. Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1/2 pathway. Chest 2009; 135(6): 1502-12.
  43. Belbasis L, Bellou V, Evangelou E, Tzoulaki I. Environmental factors and risk of multiple sclerosis: Findings from meta-analyses and Mendelian randomization studies. Mult Scler 2020; 26(4): 397-404.
  44. Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV. Smoking and multiple sclerosis: An updated meta-analysis. PLoS One 2011; 6(1): e16149.
  45. Hedstrom AK, Hossjer O, Hillert J, Stridh P, Kockum I, Olsson T, et al. The influence of human leukocyte antigen-DRB1*15:01 and its interaction with smoking in MS development is dependent on DQA1*01:01 status. Mult Scler 2020; 26(13): 1638-46.
  46. Gee JR, Chang J, Dublin AB, Vijayan N. The association of brainstem lesions with migraine-like headache: An imaging study of multiple sclerosis. Headache 2005; 45(6): 670-7.
  47. Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV. Meta-analysis of the relationship between multiple sclerosis and migraine. PLoS One 2012; 7(9): e45295.
  48. Kister I, Munger KL, Herbert J, Ascherio A. Increased risk of multiple sclerosis among women with migraine in the Nurses' Health Study II. Mult Scler 2012; 18(1): 90-7.
  49. Martinez Sobrepera HJ, Cabrera Gomez JA, Tuero Iglesias A. Exogenous factors in the aetiology of multiple sclerosis in Cuba. A study of cases and controls. Rev Neurol 2001; 33(10): 931-7.
  50. Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, et al. Risk factors of multiple sclerosis: A case-control study. Neurol Sci 2003; 24(4): 242-7.
  51. Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, et al. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study. Neurology 2017; 89(24): 2455-61.
  52. Krone B, Pohl D, Rostasy K, Kahler E, Brunner E, Oeffner F, et al. Common infectious agents in multiple sclerosis: A case-control study in children. Mult Scler 2008; 14(1): 136-9.
  53. Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study. Neurology 2004; 62(12): 2277-82.
  54. Sips GJ, Chesik D, Glazenburg L, Wilschut J, De Keyser J., Wilczak N. Involvement of morbilliviruses in the pathogenesis of demyelinating disease. Rev Med Virol 2007; 17(4): 223-44.
  55. Ahlgren C, Oden A, Bergstrom T, Lycke J. Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome. J Neuroimmunol 2012; 247(1-2): 70-4.
  56. Ahlgren C, Oden A, Toren K, Andersen O. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurol Scand 2009; 119(5): 313-20.
  57. Bachmann S, Kesselring J. Multiple sclerosis and infectious childhood diseases. Neuroepidemiology 1998; 17(3): 154-60.
  58. Sotelo J, Ordonez G, Pineda B, Flores J. The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg 2014; 119: 44-8.
  59. Kattimani Y, Veerappa AM. Complex interaction between mutant HNRNPA1 and gE of varicella zoster virus in pathogenesis of multiple sclerosis. Autoimmunity 2018; 51(4): 147-51.
  60. Lunny C, Knopp-Sihota JA, Fraser SN. Surgery and risk for multiple sclerosis: A systematic review and meta-analysis of case-control studies. BMC Neurol 2013; 13: 41.
  61. Liu Z, Zhang TT, Yu J, Liu YL, Qi SF, Zhao JJ, et al. Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: A meta-analysis. Neuroepidemiology 2016; 47(2): 103-8.
  62. Hedstrom AK, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology 2014; 82(10): 865-72.
  63. McKay KA, Jahanfar S, Duggan T, Tkachuk S, Tremlett H. Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review. Neurotoxicology 2017; 61: 189-212.
  64. Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76(6): 540-8.
  65. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010; 9(6): 599-612.
  66. Nielsen NM, Bager P, Simonsen J, Hviid A, Stenager E, Bronnum-Hansen H, et al. Major stressful life events in adulthood and risk of multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; 85(10): 1103-8.
  67. Riise T, Mohr DC, Munger KL, Rich-Edwards JW, Kawachi I, Ascherio A. Stress and the risk of multiple sclerosis. Neurology 2011; 76(22): 1866-71.
  68. Li J, Johansen C, Bronnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J. The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark. Neurology 2004; 62(5): 726-9.
  69. Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for multiple sclerosis onset or relapse: A systematic review. Neuroepidemiology 2011; 36(2): 109-20.
  70. Jacobs BM, Giovannoni G, Cuzick J, Dobson R. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Mult Scler 2020; 26(11): 1281-97.
  71. Laribi B, Shekarabi M, Zarnani AH, Ghaffarpour M, Marzban M. Differential serostatus of Epstein-Barr virus in Iranian MS patients with various clinical patterns. Med J Islam Repub Iran 2018; 32: 118.
  72. Karampoor S, Zahednasab H, Pirkouh AA, Monavari SH, Ramagopalan S, Keyvani H. Serostatus of Epstein-Barr virus in Iranian MS patients. Acta Neurol Belg 2016; 116(1): 43-6.
  73. Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: A comprehensive review. Neurol Ther 2018; 7(1): 59-85.